Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding

被引:83
作者
Schumacher, MA
Scott, DM
Mathews, II
Ealick, SE
Roos, DS
Ullman, B
Brennan, RG [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA
[3] Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA
[4] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
关键词
adenosine kinase; drug design; macromolecular crystallography; purine; Toxoplasma gondii;
D O I
10.1006/jmbi.2000.3753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adenosine kinase (AK) is a key purine metabolic enzyme from the opportunistic parasitic protozoan Toxoplasma gondii and belongs to the family of carbohydrate kinases that includes ribokinase. To understand the catalytic mechanism of AK, we determined the structures of the T. gondii apo AK, AK:adenosine complex and the AK:adenosine:AMP-PCP complex to 2.55 Angstrom, 2.50 Angstrom and 1.71 Angstrom resolution, respectively. These structures reveal a novel catalytic mechanism that involves an adenosine-induced domain rotation of 30 degrees and a newly described anion hole (DTXGAGD), requiring a helix-to-coil conformational change that is induced by ATP binding. Nucleotide binding also evokes a coil-to-helix transition that completes the formation of the ATP binding pocket. A conserved dipeptide, Gly68-Gly69, which is located at the bottom of the adenosine-binding site, functions as the switch for domain rotation. The synergistic structural changes that occur upon substrate binding sequester the adenosine and the ATP gamma phosphate from solvent and optimally position the substrates for catalysis. Finally, the 1.84 Angstrom resolution structure of an AK:7-iodotubercidin:AMP-PCP complex reveals the basis for the higher affinity binding of this prodrug over adenosine and thus provides a scaffold for the design of new inhibitors and subversive substrates that target the T. gondii AK. (C) 2000 Academic Press.
引用
收藏
页码:875 / 893
页数:19
相关论文
共 52 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   CRYSTAL-STRUCTURE OF ACTIVE ELONGATION-FACTOR TU REVEALS MAJOR DOMAIN REARRANGEMENTS [J].
BERCHTOLD, H ;
RESHETNIKOVA, L ;
REISER, COA ;
SCHIRMER, NK ;
SPRINZL, M ;
HILGENFELD, R .
NATURE, 1993, 365 (6442) :126-132
[3]   REACTION-KINETICS AND INHIBITION OF ADENOSINE KINASE FROM LEISHMANIA-DONOVANI [J].
BHAUMIK, D ;
DATTA, AK .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1988, 28 (03) :181-187
[4]  
BORK P, 1993, PROTEIN SCI, V2, P31
[5]  
Brooks R. G., 1987, Antimicrobial Agents Annual, V2, P297
[6]   DOMAIN MOVEMENTS IN PROTEIN-KINASES [J].
COX, S ;
RADZIOANDZELM, E ;
TAYLOR, SS .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1994, 4 (06) :893-901
[7]  
DAFFOS F, 1994, LANCET, V344, P541
[8]   TREATMENT OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS - A RANDOMIZED TRIAL COMPARING PYRIMETHAMINE PLUS CLINDAMYCIN TO PYRIMETHAMINE PLUS SULFADIAZINE [J].
DANNEMANN, B ;
MCCUTCHAN, JA ;
ISRAELSKI, D ;
ANTONISKIS, D ;
LEPORT, C ;
LUFT, B ;
NUSSBAUM, J ;
CLUMECK, N ;
MORLAT, P ;
CHIU, J ;
VILDE, JL ;
ORELLANA, M ;
FEIGAL, D ;
BARTOK, A ;
HESELTINE, P ;
LEEDOM, J ;
REMINGTON, J .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) :33-43
[9]   Recombinant expression, purification, and characterization of Toxoplasma gondii adenosine kinase [J].
Darling, JA ;
Sullivan, WJ ;
Carter, D ;
Ullman, B ;
Roos, DS .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1999, 103 (01) :15-23
[10]   Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene - Use as a selectable marker for stable transformation [J].
Donald, RGK ;
Carter, D ;
Ullman, B ;
Roos, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14010-14019